Skip to main content

MARSHALL WACE, LLP

Position in TBPH — Theravance Biopharma, Inc.

CIK 1318757 LONDON, X0

Position in TBPH

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$2,578,946
-$5,253,601 QoQ
Shares Held
158,900
-62.0% QoQ
Ownership
0.308%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2020
12 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in TBPH Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

MARSHALL WACE, LLP holds $2,632,800,013 across 280 Biotechnology names. TBPH ranks #132 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in TBPH

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $2,578,946 158,900
2025-12-31 $7,832,547 418,629
2025-09-30 $5,221,704 357,651
2025-06-30 $1,111,581 100,778
2025-03-31 $133,155 14,911
2024-12-31 $621,690 66,067
2024-09-30 $1,209,483 150,060
2024-06-30 $2,522,791 297,499
2024-03-31 $1,453,794 162,073
2023-09-30 $176,052 20,400
2023-06-30 $619,054 59,812
2020-06-30 $314,640 14,990